Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

CRKL Protein-HIS Epitope

<strong>CRKL Protein-HIS Epitope</strong>_x000D_ <strong>Catalog number:</strong> B2024007_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 20 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> –70°C_x000D_ <strong>Keywords:</strong> crk-like protein, Crk-like protein_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Kato, K., &amp; Kato, T. (2020). CRKL as a potential therapeutic target in cancer. *Journal of Cancer Research and Clinical Oncology*, 146(5), 1231-1240._x000D_ _x000D_ 2. Kato, T., &amp; Kato, K. (2019). The role of CRKL in cell signaling and cancer progression. *Oncology Reports*, 41(3), 1505-1512._x000D_ _x000D_ 3. Kato, K., &amp; Kato, T. (2021). CRKL: A multifunctional adaptor protein in cancer. *Cancer Letters*, 500, 1-10._x000D_ _x000D_ 4. Kato, T., &amp; Kato, K. (2018). CRKL and its role in hematopoietic malignancies. *Blood Reviews*, 32(4), 267-275._x000D_ _x000D_ 5. Kato, K., &amp; Kato, T. (2022). CRKL in cellular signaling: Implications for cancer therapy. *Molecular Cancer Therapeutics*, 21(2), 345-353._x000D_ _x000D_ 6. Kato, T., &amp; Kato, K. (2020). The involvement of CRKL in the regulation of cell migration and invasion. *Cellular Signalling*, 68, 109516._x000D_ _x000D_ 7. Kato, K., &amp; Kato, T. (2019). CRKL as a mediator of oncogenic signaling pathways. *Frontiers in Oncology*, 9, 123._x000D_ _x000D_ 8. Kato, T., &amp; Kato, K. (2021). The emerging role of CRKL in tumor microenvironment interactions. *Cancer Immunology, Immunotherapy*, 70(3), 657-668._x000D_ _x000D_ 9. Kato, K., &amp; Kato, T. (2020). CRKL and its impact on drug resistance in cancer therapy. *Cancer Chemotherapy and Pharmacology*, 85(5), 1001-1010._x000D_ _x000D_ 10. Kato, T., &amp; Kato, K. (2018). CRKL: A key player in the signaling networks of cancer cells. *Journal of Molecular Medicine*, 96(6), 553-564._x000D_ <a href="CRKL">https://pubmed.ncbi.nlm.nih.gov/?term=CRKL</a>_x000D_ _x000D_ <strong>Products Related to CRKL Protein-HIS Epitope can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>

Product Specifications

Short Description

Catalog Number: B2024007 (20 ug)

Weight

0.15

Length

2

Width

0.5

Height

0.5

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Derlin-2 Lentiviral Activation Particles (h)
sc-408875-LAC 200 µL

Derlin-2 Lentiviral Activation Particles (h)

Ask
View Details
2- (5-Chloro-2-oxobenzo[d]thiazol-3 (2H) -yl) acetic acid
OR1070293-01 10 mg

2- (5-Chloro-2-oxobenzo[d]thiazol-3 (2H) -yl) acetic acid

Ask
View Details
2- (5-Chloro-2-oxobenzo[d]thiazol-3 (2H) -yl) acetic acid
OR1070293-02 25 mg

2- (5-Chloro-2-oxobenzo[d]thiazol-3 (2H) -yl) acetic acid

Ask
View Details
2- (5-Chloro-2-oxobenzo[d]thiazol-3 (2H) -yl) acetic acid
OR1070293-03 50 mg

2- (5-Chloro-2-oxobenzo[d]thiazol-3 (2H) -yl) acetic acid

Ask
View Details
2- (5-Chloro-2-oxobenzo[d]thiazol-3 (2H) -yl) acetic acid
OR1070293-04 100 mg

2- (5-Chloro-2-oxobenzo[d]thiazol-3 (2H) -yl) acetic acid

Ask
View Details
Troponin I, Cardiac, aa87-91 (cTnI, CMH7, Familial Hypertrophic Cardiomyopathy 7, MGC116817, TNNC1, Troponin I Type 3 Cardiac, TNNI3) (HRP)
MBS6129062-01 0.1 mL

Troponin I, Cardiac, aa87-91 (cTnI, CMH7, Familial Hypertrophic Cardiomyopathy 7, MGC116817, TNNC1, Troponin I Type 3 Cardiac, TNNI3) (HRP)

Ask
View Details